Anzeige
Mehr »
Donnerstag, 21.08.2025 - Börsentäglich über 12.000 News
Potenzieller Gamechanger: Tiny-Float-Chance bei dieser Rohstoff-Aktie?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
142 Leser
Artikel bewerten:
(0)

Doceree Inc.: Doceree launches Premium Programmatic adding more context, more reach, and more formats to traditional HCP programmatic

  • With Premium Programmatic, pharma marketers can now engage physicians across 2,000+ integrated specialist medical platforms delivering clinically aligned content at scale with unmatched precision and exclusive formats.

SHORT HILLS, N.J., Aug. 21, 2025 /PRNewswire/ -- Doceree, the only AI-powered operating system for healthcare marketing, today announced the launch of Premium Programmatic-a significant step forward in HCP programmatic advertising. The platform redefines how life sciences brands can activate the reading layer of the HCP journey-a critical point where physicians consume clinical content, make decisions, and form prescribing opinions.

Doceree launches Premium Programmatic adding more context, more reach, and more formats to traditional HCP programmatic

Unlike traditional programmatic solutions, Premium Programmatic, powered by Doceree, merges scale, clinical relevance, and innovation in formats-enabling marketers to place brand messages in front of physicians at the exact moment they are learning, exploring, and searching for answers.

"Premium Programmatic brings precision, personalization, and context to every impression," said Harshit Jain, MD, Founder & Global CEO of Doceree. "We're meeting HCPs at the point of intellectual curiosity-when they're most receptive to information-and we're doing it with unmatched relevance, reach, and responsibility."

"In a landscape where brand teams often rely on large endemic platforms with limited flexibility, Premium Programmatic offers something fundamentally better: an interconnected, agile, and intelligent ecosystem where each impression is contextually more relevant, identity-verified, and format-optimized," he added.

Purpose-built for the way physicians think, search, and learn, Premium Programmatic offers marketers:

More Reach: With the largest verified HCP network

  • 2,000+ directly integrated specialist medical platforms, including medical journals, news portals, education sites, and physician communities
  • 6M+ authenticated HCPs across 45+ specialties

More Context: With precision-driven, patented targeting

  • 7M+ clinical terms, mapped using Doceree's patented MeSH-based taxonomy
  • Real-time contextual targeting ensures that brand messages appear only within relevant medical content
  • NPI-based deterministic identity matching, enhanced with device/IP data and specialty-level filtering

More Formats-By delivering what HCPs actually consume

Doceree is the only platform that enables pharmaceutical marketers to go beyond display, and deliver sponsored scientific content, including branded articles, clinical case studies, CME partnerships, and expert-driven features-right within the platforms HCPs trust for clinical messaging.

  • Content: Sponsored scientific articles delivered programmatically across the network.
  • Integrated with Sales Rep: Coming soon from Doceree--the first AI-powered sales rep, giving HCPs round-the-clock access.

These formats are optimized for how physicians learn -turning marketing into meaningful medical dialogues.

Know more about Premium Programmatic, powered by Doceree, and how it can elevate HCP engagement, visit https://doceree.com/premium-programmatic/

About Doceree

Doceree is the only AI-powered Operating System for healthcare marketing. We believe the role of AI is to bring richer context to every HCP interaction. Hence, our patented AI understands multiple layers of context to enhance every HCP interaction in a privacy-compliant manner, delivering measurably better outcomes every time. In just five years, we have emerged as leaders in AI-powered, hyper-personalized healthcare messaging - redefining HCP engagement with more powerful context and more powerful outcomes.

For more information visit www.doceree.com

Photo: https://mma.prnewswire.com/media/2755423/Doceree_Premium_Programmatic.jpg
Logo: https://mma.prnewswire.com/media/1758952/Doceree_Logo.jpg

Doceree_Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/doceree-launches-premium-programmatic-adding-more-context-more-reach-and-more-formats-to-traditional-hcp-programmatic-302535844.html

© 2025 PR Newswire
Tech-Aktien mit Crash-Tendenzen
Künstliche Intelligenz, Magnificent Seven, Tech-Euphorie – seit Monaten scheint an der Börse nur eine Richtung zu existieren: nach oben. Doch hinter den Rekordkursen lauert eine gefährliche Wahrheit. Die Bewertungen vieler Tech-Schwergewichte haben historische Extremniveaus erreicht. Shiller-KGV bei 39, Buffett-Indikator auf Allzeithoch – schon in der Dotcom-Ära war der Markt kaum teurer.

Hinzu kommen euphorische Anlegerstimmung, IPO-Hypes ohne Substanz, kreditfinanzierte Wertpapierkäufe in Rekordhöhe und charttechnische Warnsignale, die Erinnerungen an 2000 und 2021 wecken. Gleichzeitig drücken geopolitische Risiken, Trumps aggressive Zollpolitik und saisonale Börsenschwäche auf die Perspektiven.

Die Gefahr: Aus der schleichenden Korrektur könnte ein rasanter Crash werden – und der könnte vor allem überbewertete KI- und Chipwerte hart treffen.

In unserem kostenlosen Spezial-Report zeigen wir Ihnen, welche Tech-Aktien am stärksten gefährdet sind und wie Sie Ihr Depot vor dem Platzen der Blase schützen könnten.

Holen Sie sich den neuesten Report!

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.